PTCT/ 07/29/2025 · 5:15 AM PTC SEPHIENCE: A New PKU Treatment Approved FDA-approved SEPHIENCE (sepiapterin), an oral drug, treats PKU in patients 1 month+. SEPHIENCE aims to be the future standard of care.
